Current Clinical Trials
Cord blood has been successfully used for more than 20 years to treat many serious diseases.34 Today, clinical trials are investigating new therapies using a child’s own cord blood stem cells for conditions that currently have no treatment.
Several of these groundbreaking trials only use stem cells from CBR as a way of ensuring consistent quality. CBR clients have exclusive access to these FDA-regulated trials.
Current research using cord blood in regenerative medicine therapies requires a child's own stem cells and is only available to families who bank. If your child has his or her own cord blood stored with CBR and you are interested in receiving information about current and emerging clinical trials, get connected.
The CBR Center for Regenerative Medicine supports clinical trials focused on emerging newborn stem cell therapies by:
- Providing research grants to leading research institutions that are conducting regenerative medicine studies and FDA-regulated clinical trials
- Connecting our client families to relevant FDA-regulated trials
Cord blood stem cells are currently being evaluated as potential treatment for:
- Hearing loss
- Traumatic brain injury
- Cerebral palsy
- Juvenile diabetes
Clinical Trails — Exclusive to CBR Clients
Hearing Loss
A new clinical trial is laying the groundwork to help transform medical care for patients with hearing loss. This innovative study, held at Children’s Memorial Hermann Hospital in Houston, Texas, will evaluate an infusion of a child’s own (autologous) cord blood stem cells to treat acquired hearing loss. Learn more
Traumatic Brain Injury
Dr. Charles Cox, professor of pediatric surgery at The University of Texas Health Science Center in Houston (UTHealth), is leading an FDA-regulated trial studying the safety of a child's own cord blood stem cells in the treatment of traumatic brain injury (TBI).
Learn more
Cerebral Palsy
Dr. James Carroll at the Georgia Health Sciences University is conducting the first FDA-regulated clinical trial using cord blood stem cell infusions to treat children with cerebral palsy. This trial is open exclusively to children who have their cord blood banked with CBR. For more information on this study, please click here.Cerebral Palsy - Also Open to CBR Clients
Dr. Joanne Kurtzberg at Duke University is also conducting an FDA-regulated clinical trial evaluating a child's own cord blood stem cell infusions to help treat the effects of cerebral palsy.
Juvenile (Type 1) Diabetes - No Longer Recruiting
The University of Florida is in the midst of a Phase II investigation of the use of a child’s own cord blood stem cells to prolong insulin production in those suffering from juvenile (type 1) diabetes. Beginning in 2006, a group of CBR clients and other children who had been diagnosed with the condition were identified and eventually enrolled in the Phase I trial. Today, the University of Florida researchers continue their work in a Phase II study. For more information about the Phase II trial, please click here.
